chitosan has been researched along with everolimus in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiesa, E; Conti, B; Cova, E; Dorati, R; Genta, I; Meloni, F; Modena, T | 1 |
1 other study(ies) available for chitosan and everolimus
| Article | Year |
|---|---|
Hyaluronic Acid-Decorated Chitosan Nanoparticles for CD44-Targeted Delivery of Everolimus.
Topics: Adult; Antineoplastic Agents; Cell Line; Chitosan; Drug Delivery Systems; Everolimus; Fibroblasts; Humans; Hyaluronan Receptors; Hyaluronic Acid; Mesenchymal Stem Cells; Nanoparticles | 2018 |